Our website uses cookies. A cookie is a small file of letters and numbers that we put on your computer if you agree. These cookies allow us to distinguish you from other users of our website, which helps us to provide you with a good experience when you browse our website and also allows us to improve our site. Read more about the individual cookies we use and how to recognise them by clicking here.
By clicking "Allow Cookies" you agree to such use. Read more about the individual cookies we use, how to recognise them and how to withdraw your consent by clicking here.
For eye care professionals

Myopia Management

Learn about Essilor's best solution to slow down myopia progression in Children

 

Myopia Management

Myopia cannot jeopardise our children's development any longer!
 
Myopia is becoming a real public health concern across the world. The number of myopic people is increasing rapidly. The prevalence of high myopia is also expected to rise. The younger a child becomes myopic, the faster he or she will progress, leading to higher risk of developing high myopia. Intervening at the earliest possible time significantly reduces the burden. Young children are expected to be slightly hyperopic. Lower hyperopia than expected for a given age can indicate risk of myopia development.


A 2015 landmark study from Brien Holden Vision Institute (BHVI) estimates that the prevalence of myopia will increase worldwide, from 34% (2.6 billion) of the global population in 2020, to nearly 50% (5 billion) of the world population by 20501. This means that 1 in 2 people are predicted to have myopia by 2050. As a consequence, the prevalence of high myopia (≤ -5.00D) is also likely to increase from 5.2% (399 million) in 2020, to nearly 10% (1 billion) by the year 2050. These future estimates of myopia suggest that at least one billion people may be potentially at an increased risk of developing permanent vision impairment and blindness associated with high myopia.

Myopia is associated with a risk of ocular conditions such as glaucoma, cataracts, retinal detachment and myopic macular degeneration—which can lead to vision impairment or blindness. By slowing progression of myopia, it is likely that we can reduce the potential impact.

The projected increases in myopia and high myopia are widely considered to be driven by environmental factors, principally lifestyle changes resulting from a combination of decreased time outdoors and increased near work activities, among other factors.

Myopia management now represents an enormous opportunity for eye care practitioners to deliver the highest standards of care, and change the lives of many young children—as we have the tools to proactively to detect and manage it.

Essilor Is Committed To Lead The Fight Against Myopia. We are committed to bringing solutions for children to help slow down their myopia progression and prevent high myopia in the future.

Our range of Myopia Management Lenses

Stellest™ Lenses

Essilor's best solution to slow down myopic progression.

Learn more
  1. Source: Holden BA, Fricke TR, Wilson DA, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042. doi:10.1016/j.ophtha.2016.01.006
  2. Compared to single vision lenses, when worn 12 hours a day. Two-year prospective, controlled, randomized, double-masked clinical trial results on 54 myopic children wearing Stellest™ lenses compared to 50 myopic children wearing single vision lenses. Efficacy results based on 32 children who declared wearing Stellest™ lenses at least 12 hours per day every day. Bao J. et al. (2021). Myopia control with spectacle lenses with aspherical lenslets: a 2-year randomized clinical trial. Invest. Ophthalmol. Vis. Sci.; 62(8):2888.